How to Sell Your Healthcare Company and Keep Equity in the Next Phase of Growth
Key Takeaways
- Selling a healthcare company doesn’t always mean giving up all control, founders can retain equity to benefit from the next growth phase.
- Equity retention allows founders to participate in future upside while gaining liquidity from a partial sale.
- Structuring deals correctly requires strategic planning, legal guidance, and alignment with investors or acquirers.
- The right M&A advisory firm can negotiate terms that balance cash upfront and future growth participation.
- Retaining equity ensures founders remain incentivized and can continue shaping the company’s trajectory post-sale.
Introduction
Healthcare business owners face a unique challenge: how to capitalize on the value they’ve built while remaining part of the company’s future growth. Traditional exits often require founders to sell 100% of their stake, but innovative deal structures now allow partial exits with equity retention.
This approach provides liquidity, reduces risk, and positions founders to benefit from future expansion. In this article, we’ll explore why equity matters, deal structures that make it possible, and strategic steps healthcare entrepreneurs can take to maximize both cash and long-term upside.
Why Equity Retention Matters in Healthcare M&A
Retaining equity ensures that founders remain financially and operationally connected to the company’s future. In healthcare—where patient relationships, brand reputation, and deep operational knowledge drive ongoing value, staying invested is especially critical.
Experienced healthcare business brokers often recommend partial equity retention because it aligns incentives, protects continuity, and enhances deal value. Founders who maintain a meaningful stake in the company benefit from the long-term upside, ensuring their efforts continue to pay off well beyond the initial transaction.
Aligning Interests with New Investors or Acquirers
Equity retention also aligns incentives between founders and acquirers. When founders continue to contribute their expertise post-sale, buyers benefit from continuity and operational knowledge. Properly structured deals create a win-win scenario, where both parties are motivated to grow the company and maximize value.
Deal Structures That Allow Equity Retention
Healthcare founders can leverage several deal structures to retain equity while selling part of their business. A partial sale or minority stake allows founders to sell a percentage of ownership while keeping the rest, letting them benefit from future growth. Earn-out agreements tie part of the purchase price to post-sale performance metrics, ensuring founders remain incentivized. Finally, roll-over equity allows founders to reinvest a portion of proceeds into the acquiring entity to participate in future upside.
Each structure has unique advantages. Partial sales provide immediate liquidity, earn-outs encourage founders to achieve operational goals, and roll-over equity aligns founders with the long-term strategy of the acquiring company. Understanding which structure suits your goals is key to a successful transaction.
Maximizing Cash While Retaining Equity
Balancing liquidity with retained equity requires careful planning. Founders should work with experienced healthcare M&A advisors to assess valuation and negotiate terms that provide immediate cash while retaining meaningful equity. Tax implications should also be considered, as structuring deferred compensation or equity portions strategically can optimize net proceeds.
The Role of Financial Advisors
Financial advisors play a vital role in modeling scenarios to help founders determine the ideal balance between cash upfront and retained equity. Their expertise ensures that deal structures meet both personal and professional objectives, giving founders confidence that they are maximizing value.
Legal Considerations in Equity Retention Deals
Equity retention agreements involve complex legal considerations. Founders must pay attention to voting rights, board representation, and equity dilution protections. Earn-out metrics should be clearly defined to ensure fair valuation of retained equity. Engaging experienced legal counsel is essential to drafting agreements that safeguard equity, clarify obligations, and minimize risk, while allowing founders to remain actively involved.
Tax Implications of Retaining Equity
Retaining equity can have multiple tax implications. Partial sales may trigger capital gains tax on the portion sold, while retained equity may defer taxation until eventual sale or liquidity. Earn-out payments may also have unique tax treatment depending on their structure. Understanding these implications in advance allows founders to plan effectively and maximize net proceeds.
When to Consider Retaining Equity
Equity retention is most beneficial when the company has strong growth potential, there is alignment with acquirers on strategic direction, and founders want to maintain influence over operations. In healthcare, where relationships, regulatory knowledge, and operational expertise drive ongoing value, keeping a stake ensures founders continue to benefit from their efforts.
The Role of M&A Advisors in Equity Retention
Specialized healthcare M&A advisors guide founders through the complexities of equity retention deals. They assist with valuation, deal modeling, negotiation of partial sales or roll-over equity, and ensuring compliance with legal and tax requirements. Their expertise allows founders to capture immediate value while remaining connected to the company’s growth story.
Case Studies: Founders Who Benefited from Retaining Equity
Several healthcare entrepreneurs have leveraged equity retention to achieve liquidity while maintaining long-term upside. Multi-location clinics used partial sales to fund expansion while keeping a stake in the business. Specialty practices reinvested proceeds into acquiring entities via roll-over equity, participating in combined growth. Digital health startups structured earn-outs tied to operational targets, maximizing long-term returns. These examples illustrate the strategic value of balancing immediate financial gain with future participation.
Read more: Private Equity’s MedSpa Obsession: How the Right M&A Firm Puts You in Their Sights, on Your Terms
Conclusion
Selling a healthcare company doesn’t require giving up all control or future upside. Equity retention strategies provide liquidity, reduce risk, and allow founders to benefit from subsequent growth phases.
By leveraging partial sales, earn-outs, or roll-over equity, founders can remain engaged in operations, align incentives with acquirers, and maximize overall value. Working with experienced M&A advisors ensures these deals are structured strategically, legally sound, and financially optimized. Founders who plan carefully can enjoy both immediate gains and long-term participation in their company’s next phase of growth.
FAQs
1. What does it mean to retain equity when selling a healthcare company?
It means selling part of your ownership while keeping a stake in the company’s future growth and profits.
2. How does an earn-out work in healthcare M&A?
An earn-out ties part of the purchase price to post-sale performance metrics, incentivizing founders to meet operational goals.
3. What is roll-over equity?
Roll-over equity allows founders to reinvest a portion of proceeds into the acquiring entity to participate in future upside.
4. Why should I retain equity instead of selling 100%?
Equity retention allows you to benefit from future growth, maintain influence, and remain aligned with long-term success.
5. Are there tax benefits to retaining equity?
Yes, retained equity can defer taxation until eventual sale or liquidity, and proper structuring can optimize overall tax liability.
6. How do M&A advisors help with equity retention deals?
They provide valuation, modeling, negotiation support, and guidance on legal, tax, and regulatory compliance to maximize both cash and long-term upside.
7. When is retaining equity not advisable?
If the company’s future growth potential is limited, or if there is misalignment with acquirers, it may be better to pursue a full exit